232 filings
Page 7 of 12
8-K
oqakx swtac0n8e4v
9 Jan 14
Idera Expands Leadership Team and Strengthens Clinical Development Expertise in Oncology and Orphan Diseases
12:00am
8-K
qa6pysa
13 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
3cgg36ptxe
26 Sep 13
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12:00am
8-K
b63kzx1d3i xlna
24 Sep 13
Other Events
12:00am
8-K
j77jso1wa8k9po0ezh6
12 Aug 13
Other Events
12:00am
8-K
gb5531gr4ch
29 Jul 13
Material Modifications to Rights of Security Holders
12:00am
8-K
8jwjku2xo
10 Jul 13
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
12:00am
8-K
ljno64tepmmx2k smc5x
31 May 13
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
x81lc6ulnr xbb
24 May 13
Other Events
12:00am
8-K
mmk yyf7hh6
9 May 13
Other Events
12:00am
8-K
ekkhvzl6g
7 May 13
Other Events
12:00am
8-K
2ivsmxsidcul2ra
2 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
ye4nx
23 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
1x6gek6oz581n
11 Feb 13
Other Events
12:00am
8-K
z0keti dqzza601e
15 Jan 13
Other Events
12:00am
8-K
dcgmr79m
7 Dec 12
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
ojwmgqompfmz
30 Nov 12
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
951et5cw22r6ih8h8kyc
14 Nov 12
Entry into a Material Definitive Agreement
12:00am
8-K
qc9dg
15 Jun 12
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
x0u2jw
12 Jun 12
Idera Pharmaceuticals Receives Nasdaq Listing Notice
12:00am